A promising development has occurred for osteoarthritis, a joint disease that diminishes the quality of life for millions worldwide. An experimental treatment developed under a new research program in the US is reported to be able to repair damaged joints with just a single injection within weeks. Researchers announced that joint tissues returned to a healthy state within a few weeks in animal experiments.
No Definitive Treatment
Osteoarthritis, commonly known as "calcification" (kireçlenme), occurs when the cartilage tissue that prevents bones from rubbing against each other in the joints wears down over time. As the disease progresses, pain, inflammation, restricted movement, and joint deformity can develop. Currently, there is no definitive cure for osteoarthritis. Patients often have to resort to pain management methods or, in advanced cases, prosthetic surgery. 240 million people worldwide are affected by this disease.
The Advanced Research Projects Agency for Health (ARPA-H), operating under the US Department of Health and Human Services, has launched a comprehensive support program for projects aimed at treating osteoarthritis. One of the most notable studies under this program, called NITRO, is being conducted at the University of Colorado Boulder.
The university's research team received $33.5 million in funding to develop the project. Biomedical engineer Stephanie Bryant is leading the study. The primary goal of the research is not just to reduce pain, but to directly reverse joint damage.
Utilizing the Body's Natural Healing Mechanism
The most striking aspect of the new approach is that it directly leverages the body's natural regenerative capacity instead of artificial joints or synthetic tissue. Researchers have developed a system that activates the body's own cells to repair the damaged area.
The first treatment method is administered via a single injection. In this method, an already approved drug is delivered to the joint in a controlled manner through a special particle delivery system. This ensures that the drug reaches the damaged joint area in low doses for months, triggering natural repair processes.
The second method was developed for more advanced cases of osteoarthritis. This approach uses a special structure composed of biomaterials and proteins. The material, placed into the joint through minimally invasive procedures, solidifies within the body, acting as a scaffold. This structure attracts progenitor cells to the damaged area and supports the regeneration of both cartilage and bone tissue.
According to the researchers, the common goal of both methods is to transform the diseased joint environment back into one conducive to natural healing.
Remarkable Results in Animal Experiments
According to data released by the research team, the treated joints in animal experiments returned to a healthy state within 4 to 8 weeks. In cases with more severe damage, complete regeneration of damaged tissues was observed.
Researchers also conducted experiments with cells taken from humans who had undergone joint replacement surgery. These tests also showed significant regenerative effects. The results indicate that the method could be applicable to humans.
Despite this, scientists specifically emphasize that the current findings have not yet been confirmed by clinical trials. The research team plans to publish its results in an academic journal within the year.
Furthermore, a startup company called Renovare Therapeutics has been established to commercialize the project. The company's goal is to advance the treatment to the clinical use stage.
Researchers are now preparing to conduct more comprehensive animal experiments, specifically analyzing safety and toxicity data. If the process proceeds as planned, the first human clinical trials are expected to begin in approximately 18 months.
0 Comments: